Table 4: ACE inhibitor questionnaire.

Characteristics	No. of patients (N = 111)
Reported side effects	72 (64.9%)
Reported dry cough	68 (61.3%)
Reported throat clearing	61 (55%)
Reported dry throat	59 (53.2%)
Presence of symptoms after discontinuation of ACE inhibitor	11 (9.9%)
Still use ACE inhibitor	38 (34.2%)
Switched to ARB	69 (62.2%)

Data are expressed as number of patients (percentage). ACE: Angiotensin-Converting Enzyme; ARB: Angiotensin Receptor Blocker.